ARIX Bioscience Plc Announces Board Changes, Appointment of Arthur Pappas to the Board of Directors, David U’Prichard to retire from Board

LONDON, 12 September 2018: Arix Bioscience plc (“Arix”) (LSE: ARIX), a global healthcare and life science company supporting medical innovation, today announced that industry veteran Arthur Pappas has been appointed as Non-Executive Director to the Arix Board of Directors. Arix also announces, David U’Prichard is retiring from the Board, effective immediately.

Read more

By Optimum

For more information about Optimum Strategic Communications, please get in touch

We'd love to hear from you...